U.S. Court in Pennsylvania Refuses to Certify Nationwide Class Where State Law Remedies Conflict
- November 13, 2020
The U.S. District Court for the Eastern District of Pennsylvania refused November 6 to certify a nationwide class in connection with litigation over the drug Elmiron, a medication designed, marketed, and distributed by Janssen Pharmaceuticals, Inc.
ARTICLE TAGS
You must be logged in to access this content.